Certified Global Research Member

Isomar fd.webp

Wcrc 57.webp

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players’ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Eye Allergy Treatment Market Application And Share Analysis By Type (Vernal Keratoconjunctivitis, Atopic Keratoconjunctivitis, & Contact Allergic Conjunctivitis), Treatment (Medications & Allergy Shots), And End User (Hospitals & Clinics)-Forecast Till 2030

ID: MRFR/Pharma/2523-CR | 159 Pages | Author: Rahul Gotadki| April 2019

Leading companies partner with us for data-driven Insights

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

1 Report Prologue

2 Introduction

2.1 Definition 17

2.2 Scope of the Study 17

2.3 List of Assumptions 18

2.4 Market Structure 18

3 Research Methodology

3.1 Research Process 20

3.2 Primary Research 21

3.3 Secondary Research 22

3.4 Market Size Estimation 23

3.5 Forecast Model 23

4 Market Dynamics

4.1 Introduction 25

4.2 Drivers 26

4.2.1 Increasing prevalence of ophthalmological disorders 26

4.2.2 Favorable government funding 26

4.2.3 Product advancements 26

4.3 Restraints 27

4.3.1 Lack of awareness 27

4.3.2 Side-effects of certain eye allergy treatments 27

4.4 Opportunity 27

4.4.1 Emerging markets of eye allergy treatment 27

4.5 Mega Trends 28

4.5.1 Technological Trends 28

4.6 Macroeconomics 28

5 Market Factor Analysis

5.1 Porter’s Five Forces Analysis 30

5.1.1 Bargaining Power of Suppliers 30

5.1.2 Bargaining Power of Buyers 30

5.1.3 Threat of New Entrants 31

5.1.4 Threat of Substitutes 31

5.1.5 Intensity of Rivalry 31

5.2 Investment Opportunity Analysis 31

5.3 Pricing Analysis 31

5.4 Demand & Supply: Gap Analysis 32

5.5 Merger and Acquisition Landscape 32

5.6 Value Chain Analysis 32

5.6.1 R&D 33

5.6.2 Manufacturing 33

5.6.3 Distribution & Sales 33

5.6.4 Post-Sales Monitoring 33

6 Eye Allergy Treatment Market, by Type

6.1 Introduction 35

6.2 Seasonal and Perennial Allergic Conjunctivitis 36

6.3 Vernal Keratoconjunctivitis 37

6.4 Atopic Keratoconjunctivitis 37

6.5 Contact Allergic Conjunctivitis 38

6.6 Giant Papillary Conjunctivitis 38

7 Eye Allergy Treatment Market, by Treatment

7.1 Introduction 40

7.2 Medications 41

7.2.1 Artificial Tears 43

7.2.2 Decongestants 43

7.2.3 Antihistamine/Mast-Cell Stabilizers 44

7.2.4 Oral Antihistamines 44

7.2.5 Corticosteroids 45

7.3 ALLERGY SHOTS (Immunotherapy) 46

7.3.1 Subcutaneous Immunotherapy Treatment (SCIT) 47

7.3.2 Sublingual Immunotherapy Treatment (SLIT) 48

8 Eye Allergy Treatment Market, by End User

8.1 Introduction 50

8.2 Hospitals and Clinics 51

8.3 Specialty Centers 51

9 Global Eye Allergy Treatment Market, by Region

9.1 Introduction 53

9.2 Americas 55

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.2.1 North America 58

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.2.1.1 US 62

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.2.1.2 Canada 64

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.2.2 Latin America 67

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.3 Europe 70

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.3.1 Western Europe 73

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.3.1.1 Germany 77

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.3.1.2 France 79

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.3.1.3 UK 82

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.3.1.4 Italy 84

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.3.1.5 Spain 87

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.3.1.6 Rest of Western Europe 89

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.3.2 Eastern Europe 92

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.4 Asia-Pacific 95

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.4.1 Japan 98

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.4.2 China 101

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.4.3 India 103

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.4.4 Australia 106

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.4.5 South Korea 108

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.4.6 Rest of Asia-Pacific 111

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.5 Middle East and Africa 114

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.5.1 Middle East 117

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.5.1.1 Saudi Arabia 121

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.5.1.2 UAE 123

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.5.1.3 Egypt 126

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.5.1.4 Rest of Middle East 128

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

9.5.2 Africa 131

Eye Allergy Treatment Market, by Type

Eye Allergy Treatment Market, by Treatment

Eye Allergy Treatment Market, by End User

10 Company Landscape

10.1 Company Share Analysis 135

11 Company Profile

11.1 Allergan Plc 138

11.1.1 Company Overview 138

11.1.2 Financial Overview 138

11.1.3 Products/Services Offered 139

11.1.4 Key Developments 139

11.1.5 SWOT Analysis 139

11.1.6 Key Strategies 139

11.2 Johnson & Johnson Services Inc. 140

11.2.1 Company Overview 140

11.2.2 Financial Overview 140

11.2.3 Products/Services Offered 141

11.2.4 Key Developments 141

11.2.5 SWOT Analysis 141

11.2.6 Key Strategies 141

11.3 Novartis AG 142

11.3.1 Company Overview 142

11.3.2 Financial Overview 142

11.3.3 Products/Services Offered 143

11.3.4 Key Developments 143

11.3.5 SWOT Analysis 143

11.3.6 Key Strategies 143

11.4 Bausch Health (Valeant Pharmaceuticals International Inc.) 144

11.4.1 Company Overview 144

11.4.2 Financial Overview (Valeant Pharmaceuticals International Inc.) 144

11.4.3 Products/Services Offered 145

11.4.4 SWOT Analysis 145

11.4.5 Key Developments 145

11.4.6 Key Strategies 145

11.5 Santen Pharmaceutical Co. Ltd 146

11.5.1 Company Overview 146

11.5.2 Financial Overview 146

11.5.3 Products/Services Offered 147

11.5.4 SWOT Analysis 147

11.5.5 Key Developments 147

11.5.6 Key Strategies 147

11.6 Teva Pharmaceutical Industries Ltd 148

11.6.1 Company Overview 148

11.6.2 Financial Overview 148

11.6.3 Products/Services Offered 149

11.6.4 Key Developments 149

11.6.5 SWOT Analysis 149

11.6.6 Key Strategies 149

11.7 Nicox 150

11.7.1 Company Overview 150

11.7.2 Financial Overview 150

11.7.3 Products/Services Offered 150

11.7.4 SWOT Analysis 150

11.7.5 Key Developments 150

11.7.6 Key Strategies 150

11.8 Akorn Inc. 151

11.8.1 Company Overview 151

11.8.2 Financial Overview 151

11.8.3 Products/Services Offered 152

11.8.4 SWOT Analysis 152

11.8.5 Key Developments 152

11.8.6 Key Strategies 152

11.9 Shire 153

11.9.1 Company Overview 153

11.9.2 Financial Overview 153

11.9.3 Products/Services Offered 154

11.9.4 SWOT Analysis 154

11.9.5 Key Developments 154

11.9.6 Key Strategies 154

11.10 Nutra Essential OTC 155

11.10.1 Company Overview 155

11.10.2 Financial Overview 155

11.10.3 Products/Services Offered 155

11.10.4 SWOT Analysis 155

11.10.5 Key Developments 155

11.10.6 Key Strategies 155

12 Appendix

12.1 Discussion Blueprint 157

12.2 References 158

13 List of Tables

TABLE 1 LIST OF ASSUMPTIONS 18

TABLE 2 GLOBAL EYE ALLERGY TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 36

TABLE 3 GLOBAL EYE ALLERGY TREATMENT MARKET FOR SEASONAL AND PERENNIAL ALLERGIC CONJUNCTIVITIS, BY REGION,

2020–2027 (USD MILLION) 36

TABLE 4 GLOBAL EYE ALLERGY TREATMENT MARKET FOR VERNAL KERATOCONJUNCTIVITIS, BY REGION, 2020–2027 (USD MILLION) 37

TABLE 5 GLOBAL EYE ALLERGY TREATMENT MARKET FOR ATOPIC KERATOCONJUNCTIVITIS, BY REGION, 2020–2027 (USD MILLION) 37

TABLE 6 GLOBAL EYE ALLERGY TREATMENT MARKET FOR CONTACT ALLERGIC CONJUNCTIVITIS, BY REGION,

2020–2027 (USD MILLION) 38

TABLE 7 GLOBAL EYE ALLERGY TREATMENT MARKET FOR GIANT PAPILLARY CONJUNCTIVITIS, BY REGION, 2020–2027 (USD MILLION) 38

TABLE 8 GLOBAL EYE ALLERGY TREATMENT MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 41

TABLE 9 GLOBAL EYE ALLERGY TREATMENT MARKET FOR MEDICATIONS, BY TYPE, 2020–2027 (USD MILLION) 42

TABLE 10 GLOBAL EYE ALLERGY TREATMENT MARKET FOR MEDICATIONS, BY REGION, 2020–2027 (USD MILLION) 42

TABLE 11 GLOBAL EYE ALLERGY TREATMENT MARKET FOR ARTIFICIAL TEARS, BY REGION, 2020–2027 (USD MILLION) 43

TABLE 12 GLOBAL EYE ALLERGY TREATMENT MARKET FOR DECONGESTANTS, BY REGION, 2020–2027 (USD MILLION) 43

TABLE 13 GLOBAL EYE ALLERGY TREATMENT MARKET FOR ANTIHISTAMINE/MAST-CELL STABILIZERS, BY REGION,

2020–2027 (USD MILLION) 44

TABLE 14 GLOBAL EYE ALLERGY TREATMENT MARKET FOR ORAL ANTIHISTAMINES, BY REGION, 2020–2027 (USD MILLION) 44

TABLE 15 GLOBAL EYE ALLERGY TREATMENT MARKET FOR CORTICOSTEROIDS, BY REGION, 2020–2027 (USD MILLION) 45

TABLE 16 GLOBAL EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020–2027 (USD MILLION) 46

TABLE 17 GLOBAL EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY REGION,

2020–2027 (USD MILLION) 47

TABLE 18 GLOBAL EYE ALLERGY TREATMENT MARKET FOR SUBCUTANEOUS IMMUNOTHERAPY TREATMENT (SCIT), BY REGION,

2020–2027 (USD MILLION) 47

TABLE 19 GLOBAL EYE ALLERGY TREATMENT MARKET FOR SUBLINGUAL IMMUNOTHERAPY TREATMENT (SLIT), BY REGION,

2020–2027 (USD MILLION) 48

TABLE 20 GLOBAL EYE ALLERGY TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 50

TABLE 21 GLOBAL EYE ALLERGY TREATMENT MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020–2027 (USD MILLION) 51

TABLE 22 GLOBAL EYE ALLERGY TREATMENT MARKET FOR SPECIALTY CENTERSS, BY REGION, 2020–2027 (USD MILLION) 51

TABLE 23 GLOBAL EYE ALLERGY TREATMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 54

TABLE 24 AMERICAS: EYE ALLERGY TREATMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 55

TABLE 25 AMERICAS: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 56

TABLE 26 AMERICAS: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 56

TABLE 27 AMERICAS: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 57

TABLE 28 AMERICAS: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

2020-2027 (USD MILLION) 57

TABLE 29 AMERICAS: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 58

TABLE 30 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 59

TABLE 31 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 59

TABLE 32 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 60

TABLE 33 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 60

TABLE 34 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

2020-2027 (USD MILLION) 61

TABLE 35 NORTH AMERICA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 61

TABLE 36 US: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 62

TABLE 37 US: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 62

TABLE 38 US: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 63

TABLE 39 US: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 63

TABLE 40 US: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 64

TABLE 41 CANADA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 64

TABLE 42 CANADA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 65

TABLE 43 CANADA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 65

TABLE 44 CANADA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 66

TABLE 45 CANADA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 66

TABLE 46 LATIN AMERICA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 67

TABLE 47 LATIN AMERICA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 67

TABLE 48 LATIN AMERICA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 68

TABLE 49 LATIN AMERICA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

2020-2027 (USD MILLION) 68

TABLE 50 LATIN AMERICA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 69

TABLE 51 EUROPE: EYE ALLERGY TREATMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 70

TABLE 52 EUROPE: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 71

TABLE 53 EUROPE: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 71

TABLE 54 EUROPE: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 72

TABLE 55 EUROPE: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 72

TABLE 56 EUROPE: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 73

TABLE 57 WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 74

TABLE 58 WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 74

TABLE 59 WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 75

TABLE 60 WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 75

TABLE 61 WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

2020-2027 (USD MILLION) 76

TABLE 62 WESTERN EUROPE: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 76

TABLE 63 GERMANY: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 77

TABLE 64 GERMANY: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 77

TABLE 65 GERMANY: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 78

TABLE 66 GERMANY: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

2020-2027 (USD MILLION) 78

TABLE 67 GERMANY: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 79

TABLE 68 FRANCE: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 79

TABLE 69 FRANCE: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 80

TABLE 70 FRANCE: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 80

TABLE 71 FRANCE: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 81

TABLE 72 FRANCE: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 81

TABLE 73 UK: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 82

TABLE 74 UK: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 82

TABLE 75 UK: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 83

TABLE 76 UK: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 83

TABLE 77 UK: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 84

TABLE 78 ITALY: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 84

TABLE 79 ITALY: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 85

TABLE 80 ITALY: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 85

TABLE 81 ITALY: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 86

TABLE 82 ITALY: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 86

TABLE 83 SPAIN: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 87

TABLE 84 SPAIN: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 87

TABLE 85 SPAIN: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 88

TABLE 86 SPAIN: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 88

TABLE 87 SPAIN: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 89

TABLE 88 REST OF WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 89

TABLE 89 REST OF WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 90

TABLE 90 REST OF WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 90

TABLE 91 REST OF WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

2020-2027 (USD MILLION) 91

TABLE 92 REST OF WESTERN EUROPE: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 91

TABLE 93 EASTERN EUROPE: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 92

TABLE 94 EASTERN EUROPE: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 92

TABLE 95 EASTERN EUROPE: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 93

TABLE 96 EASTERN EUROPE: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

2020-2027 (USD MILLION) 93

TABLE 97 EASTERN EUROPE: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 94

TABLE 98 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 95

TABLE 99 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 96

TABLE 100 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 96

TABLE 101 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 97

TABLE 102 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

2020-2027 (USD MILLION) 97

TABLE 103 ASIA-PACIFIC: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 98

TABLE 104 JAPAN: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 98

TABLE 105 JAPAN: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 99

TABLE 106 JAPAN: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 99

TABLE 107 JAPAN: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 100

TABLE 108 JAPAN: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 100

TABLE 109 CHINA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 101

TABLE 110 CHINA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 101

TABLE 111 CHINA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 102

TABLE 112 CHINA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 102

TABLE 113 CHINA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 103

TABLE 114 INDIA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 103

TABLE 115 INDIA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 104

TABLE 116 INDIA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 104

TABLE 117 INDIA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 105

TABLE 118 INDIA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 105

TABLE 119 AUSTRALIA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 106

TABLE 120 AUSTRALIA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 106

TABLE 121 AUSTRALIA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 107

TABLE 122 AUSTRALIA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 107

TABLE 123 AUSTRALIA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 108

TABLE 124 SOUTH KOREA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 108

TABLE 125 SOUTH KOREA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 109

TABLE 126 SOUTH KOREA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 109

TABLE 127 SOUTH KOREA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

2020-2027 (USD MILLION) 110

TABLE 128 SOUTH KOREA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 110

TABLE 129 REST OF ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 111

TABLE 130 REST OF ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 111

TABLE 131 REST OF ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 112

TABLE 132 REST OF ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

2020-2027 (USD MILLION) 112

TABLE 133 REST OF ASIA-PACIFIC: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 113

TABLE 134 MIDDLE EAST AND AFRICA: EYE ALLERGY TREATMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 114

TABLE 135 MIDDLE EAST AND AFRICA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 115

TABLE 136 MIDDLE EAST AND AFRICA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 115

TABLE 137 MIDDLE EAST AND AFRICA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 116

TABLE 138 MIDDLE EAST AND AFRICA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

2020-2027 (USD MILLION) 116

TABLE 139 MIDDLE EAST AND AFRICA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 117

TABLE 140 MIDDLE EAST: EYE ALLERGY TREATMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 118

TABLE 141 MIDDLE EAST: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 118

TABLE 142 MIDDLE EAST: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 119

TABLE 143 MIDDLE EAST: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 119

TABLE 144 MIDDLE EAST: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

2020-2027 (USD MILLION) 120

TABLE 145 MIDDLE EAST: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 120

TABLE 146 SAUDI ARABIA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 121

TABLE 147 SAUDI ARABIA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 121

TABLE 148 SAUDI ARABIA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 122

TABLE 149 SAUDI ARABIA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

2020-2027 (USD MILLION) 122

TABLE 150 SAUDI ARABIA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 123

TABLE 151 UAE: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 123

TABLE 152 UAE: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 124

TABLE 153 UAE: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 124

TABLE 154 UAE: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 125

TABLE 155 UAE: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 125

TABLE 156 EGYPT: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 126

TABLE 157 EGYPT: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 126

TABLE 158 EGYPT: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 127

TABLE 159 EGYPT: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 127

TABLE 160 EGYPT: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 128

TABLE 161 REST OF MIDDLE EAST: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 128

TABLE 162 REST OF MIDDLE EAST: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 129

TABLE 163 REST OF MIDDLE EAST: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 129

TABLE 164 REST OF MIDDLE EAST: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

2020-2027 (USD MILLION) 130

TABLE 165 REST OF MIDDLE EAST: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 130

TABLE 166 AFRICA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 131

TABLE 167 AFRICA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 131

TABLE 168 AFRICA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 132

TABLE 169 AFRICA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 132

TABLE 170 AFRICA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 133

14 List of Figures

FIGURE 1 GLOBAL EYE ALLERGY TREATMENT MARKET: MARKET STRUCTURE 18

FIGURE 2 RESEARCH PROCESS OF MRFR 20

FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACHES 23

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL EYE ALLERGY TREATMENT MARKET 25

FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: GLOBAL EYE ALLERGY TREATMENT MARKET 30

FIGURE 6 VALUE CHAIN - GLOBAL EYE ALLERGY TREATMENT MARKET 32

FIGURE 7 GLOBAL EYE ALLERGY TREATMENT MARKET, BY TYPE, 2020 & 2027 (USD MILLION) 35

FIGURE 8 GLOBAL EYE ALLERGY TREATMENT MARKET, BY TREATMENT, 2020 & 2027 (USD MILLION) 40

FIGURE 9 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR MEDICATIONS, BY TYPE, 2020 & 2027 (USD MILLION) 41

FIGURE 10 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

2020 & 2027 (USD MILLION) 46

FIGURE 11 GLOBAL EYE ALLERGY TREATMENT MARKET, BY END USER, 2020 & 2027 (USD MILLION) 50

FIGURE 12 GLOBAL EYE ALLERGY TREATMENT MARKET, BY REGION, 2020 & 2027 (USD MILLION) 54

FIGURE 13 AMERICAS: EYE ALLERGY TREATMENT MARKET SHARE, BY REGION,2020 (%) 55

FIGURE 14 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET SHARE, BY COUNTRY,2020 (%) 58

FIGURE 15 EUROPE: EYE ALLERGY TREATMENT MARKET SHARE, BY REGION,2020 (%) 70

FIGURE 16 WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET SHARE, BY COUNTRY,2020 (%) 73

FIGURE 17 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET SHARE, BY COUNTRY,2020 (%) 95

FIGURE 18 MIDDLE EAST AND AFRICA: EYE ALLERGY TREATMENT MARKET SHARE, BY REGION,2020 (%) 114

FIGURE 19 MIDDLE EAST: EYE ALLERGY TREATMENT MARKET SHARE, BY COUNTRY,2020 (%) 117

FIGURE 20 GLOBAL EYE ALLERGY TREATMENT MARKET, COMPANY SHARE ANALYSIS, 2020 135

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.

Press Release

pr-img

Eye allergy treatment Market Projected to Grow Radiantly By 2030; Asserts MRFR Unleashing Industr...

FEATURES	LICENCE TYPE
FEATURES	Single User	Multiuser Licence	Enterprise User
Price	$ 4,950	$ 5,950	$ 7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout The Organization.
Free Customization
Direct access to the Analyst
Deliverable Format
Deliverable Format
Platform Access
Discount on Your Next Purchase	10%	15%	10%
Printable Versions

© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)